Table 4.

The HLA-G allele frequencies in the women and men with antiphospholipid syndrome (APS), preeclampsia (PE), intrauterine growth restriction (IUGR), recurrent spontaneous abortion (RSA), and the control group (C).

HLA-G Allele	APS				PE				IUGR				RSA				C
	Women n = 70		Men n = 54		Women n = 48		Men n = 43		Women n = 35		Men n = 34		Women n = 58		Men n = 58		Women n = 89		Men n = 86
	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%
105N	2	1.43	3	2.78	2	2.08	0	0.00	1	1.47	0	0.00	4	3.45	1	0.86	3	1.69	3	1.74
103	0	0.00	1	0.93	0	0.00	0	0.00	1	1.47	0	0.00	2	1.72	1	0.86	0	0.00	0	0.00
106	10	7.14	7	6.48	1	1.04	7	8.14	2	2.94	4	5.71	4	3.45	5	4.31	5	2.81	6	3.49
10101	50	35.71	49	45.37	43	44.79	41	47.67	39	57.35	33	47.14	61	52.59	55	47.41	86	48.31	89	51.74
10102	38	27.14	25	23.15	26	27.08	22	25.58	13	19.12	23	32.86	25	21.55	30	25.86	50	28.09	39	22.67
10103	7	5.00	5	4.63	4	4.17	2	2.33	4	5.88	3	4.29	5	4.31	8	6.90	11	6.18	12	6.98
10104	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	1	0.86	0	0.00	0	0.00
10105	0	0.00	0	0.00	1	1.04	0	0.00	0	0.00	0	0.00	0	0.00	1	0.86	0	0.00	1	0.58
10106	0	0.00	2	1.85	1	1.04	1	1.16	1	1.47	2	2.86	1	0.86	1	0.86	6	3.37	1	0.58
10107	1	0.71	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	2	1.16
10108	12	8.57	5	4.63	14	14.58	9	10.47	4	5.88	2	2.86	8	6.90	5	4.31	5	2.81	9	5.23
10109	1	0.71	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00
10110	3	2.14	3	2.78	2	2.08	0	0.00	0	0.00	2	2.86	1	0.86	1	0.86	1	0.56	1	0.58
10401	13	9.29	5	4.63	2	2.08	4	4.65	2	2.94	0	0.00	5	4.31	7	6.03	9	5.06	9	5.23
10402	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	1	0.56	0	0.00
10403	3	2.14	3	2.78	0	0.00	0	0.00	1	1.47	1	1.43	0	0.00	0	0.00	1	0.56	0	0.00
Total	140	100	108	100	96	100	86	100	68	100	70	100	116	100	116	100	178	100	172	100